Cleven Injection 6000 Anti-Xa IU/0.6 ml contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) widely used for the prevention and treatment of thromboembolic disorders. It is designed to reduce the risk of abnormal blood clot formation, which can lead to serious medical conditions such as deep vein thrombosis and pulmonary embolism. This strength is commonly used in both prophylactic and therapeutic anticoagulation depending on patient weight and clinical indication.

Cleven Injection offers reliable anticoagulant activity with predictable pharmacokinetics, making it suitable for use in hospital as well as supervised outpatient settings.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition and Mechanism of Action

Enoxaparin Sodium 6000 Anti-Xa IU/0.6 ml

Enoxaparin Sodium acts by potentiating the effect of antithrombin III, leading to selective inhibition of coagulation factor Xa and partial inhibition of thrombin (factor IIa). Its therapeutic actions include:

• Prevention of fibrin clot formation

• Inhibition of clot extension and recurrence

• Maintenance of normal blood flow without significantly affecting platelet aggregation

This targeted mechanism provides effective anticoagulation with a reduced risk of bleeding compared to unfractionated heparin.

Indications

Cleven Injection 6000 Anti-Xa IU/0.6 ml is indicated for:

• Prevention of deep vein thrombosis following general or orthopedic surgery

• Prevention of thromboembolic complications in immobilized medical patients

• Treatment of deep vein thrombosis with or without pulmonary embolism

• Management of unstable angina and non-ST elevation myocardial infarction

• Anticoagulation during hemodialysis procedures

The choice of dose depends on clinical assessment, body weight, and risk factors.

Benefits of Cleven Injection

• Predictable anticoagulant response

• Lower incidence of heparin-induced thrombocytopenia

• Reduced need for routine coagulation monitoring

• Convenient subcutaneous administration

• Proven efficacy in preventing and treating blood clots

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Dosage and Administration

• Dosage and duration should be determined by a healthcare professional

• Administered via subcutaneous injection

• Injection should be given in the abdominal area, with sites rotated regularly

• Should not be administered intramuscularly

Patients and caregivers should follow medical instructions carefully.

Safety Information and Precautions

Possible Side Effects

Some patients may experience:

• Bleeding or bruising at the injection site

• Thrombocytopenia

• Anemia

• Mild elevation of liver enzymes

• Local pain or redness

Seek immediate medical attention if severe bleeding or allergic reactions occur.

Precautions

• Contraindicated in patients with active major bleeding

• Use with caution in renal impairment and elderly patients

• Regular platelet count monitoring may be advised

• Inform your doctor about all concomitant medications, especially anticoagulants or antiplatelet agents

• Use during pregnancy or breastfeeding only if prescribed

Storage Conditions

• Store at the temperature recommended on the label

• Protect from direct light

• Do not freeze

• Keep out of reach of children

Conclusion

Cleven Injection 6000 Anti-Xa IU/0.6 ml (Enoxaparin Sodium) is a trusted anticoagulant therapy for the prevention and treatment of thromboembolic conditions. Its reliable efficacy, predictable action, and ease of use make it an essential component of modern anticoagulation management when used under appropriate medical supervision.